Avalyn Pharma Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, Avalyn Pharma stock has a consensus rating of "Strong Buy" and an average price target of $59. The average 1-year stock price forecast is 105.00% higher than the current stock price, while the lowest is $51 (+77.21%) and the highest is $80 (+177.97%).

Price Target: $59 (+105.00%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$51	$59	$52.5	$80
Change	+77.21%	+105.00%	+82.42%	+177.97%

Analyst Ratings

The average analyst rating for Avalyn Pharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	May '26
Strong Buy	3
Buy	1
Hold	0
Sell	0
Strong Sell	0
Total	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Gavin Clark-Gartner Evercore ISI	Evercore ISI	Buy Initiates $51	Buy	Initiates	$51	+77.21%	May 26, 2026
Judah Frommer Morgan Stanley	Morgan Stanley	Buy Initiates $53	Buy	Initiates	$53	+84.16%	May 26, 2026
Roger Song Jefferies	Jefferies	Buy Initiates $52	Buy	Initiates	$52	+80.68%	May 25, 2026

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

n/a

EPS Next Year

n/a

No financial forecasts available for this stock

Revenue Forecast

No data available

Revenue Growth

No data available

EPS Forecast

No data available

EPS Growth

No data available

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.